ABSTRACT-The pharmacological properties of 2-butyl-4-(methylthio)-1- [[2 [[[(propylamino)carbonyl] amino] sulfonyl](1,1 biphenyl)-4-yl]methyl]-1H-imidazole-5-carboxylate (HR720), a novel non-peptide angiotensin (Ang) II type I (AT1) receptor antagonist, were characterized in both in vitro and in vivo systems. In vitro autoradiography using 125I-[Sar1,IIe8]Ang II as a ligand revealed that HR720 competitively inhibited the specific binding of the ligand to the adrenal cortex. The IC50 value for the adrenal cortex was 1.5 x 10-8 M, and the IC50 for medulla was 1.4 x 10-6 M. Similar results were obtained in the adrenal cortex with CV-11974, a known potent AT1-receptor antagonist. Since AT1 receptors are known to predominate in the adrenal cortex and AT2-receptors in the adrenal medulla, it is considered that HR720 is highly selective for AT, receptors. HR720 inhibited the Ang II-induced contraction of isolated rabbit aortic strips and hu man gastroepiploic arteries in a noncompetitive manner, pD'2=9.40 and 9.62 for rabbit aorta and human artery, respectively. With CV-11974, pD'2 values of 9.84 in isolated rabbit aorta and 10.00 in human artery were obtained. HR720 did not affect the norepinephrine-, serotonin or KCl-induced contraction even at a concentration of 1 x 10-5 M. In anesthetized hamsters, HR720 induced a dose-dependent inhibition of the pressure response to Ang II. The potency of HR720 to antagonize the Ang II-induced pressure response was similar to that of CV-11974. These results demonstrate that HR720 is a potent and selective AT1 -receptor antagonist.
The renin-angiotensin system (RAS) plays a critical role in blood pressure regulation and in fluid and electrolytes homeostasis; it is also involved in the pathogenesis of many cardiovascular diseases (1, 2) . The RAS consists of a cascade of enzymatic reactions leading to formation of angiotensin (Ang) II which is a powerful vasoconstrictor. The angiotensin converting enzyme (ACE) inhibitors have clearly demonstrated the beneficial effect of pharmacological inhibition of the RAS in the treatment of hypertension and congestive heart failure (3). Recent studies have suggested that ACE inhibitors effectively prevented the progression of atherosclerosis in high cholesterol loaded rabbit aorta (4, 5) and inhibited the progression of renal damage in the rat model of chronic renal failure (6, 7) , indicating the involvement of Ang II in such pathological disorders. However, there are many reports on the unwanted side effects of ACE inhibitors such as cough and angioedema resulting from the lack of * To whom correspondence should be addressed .
specificity of ACE inhibitors for Ang I (8, 9) . Moreover, ACE inhibitors interfere with the kinin metabolism (10) . Recent studies have demonstrated that Ang II can also be formed in non-ACE-dependent manner in several species of animals including humans (11) (12) (13) . In view of these limitations of ACE inhibitors, selective blocking of Ang II receptor appears to be a more reasonable approach to block RAS.
As a result of the development of new classes of Ang II-receptor antagonist, two distinct subtypes of Ang 11 receptor are identified. A standard nomenclature for Ang II receptor subtypes are proposed, in which the Ang II receptors inhibited by losartan, a prototypic Ang II type I (AT,)-receptor antagonist, are designated AT, recep tors and those inhibited by PD123177, PD123319 or CGP42112A are designated as AT2 receptors (14) . AT, receptors are believed to be responsible for the known biological actions of Ang II, while a possible function of AT2 receptors is to mediate apoptosis (15 -17) . In this study, we describe the pharmacological profiles of a novel nonpeptide AT,-receptor antagonist, HR720 (2-butyl-4
ylate, MW 620.88) (Fig. 1 ).
MATERIALS AND METHODS
Binding assay for Ang II receptors in rat adrenal gland Ang II receptors were labeled by in vitro autoradio graphy with 125I-[Sar1,11e8]Ang II as a ligand (18) . Male Wistar rats (300-350g; Japan SLC, Shizuoka) were decapitated, and then their adrenal glands were promptly removed, frozen in isopentane-dry ice (-40'C) and stored at -80'C. Serial 20-,um sections were cut on a cryostat, thaw-mounted onto gelatin-coated slides and dried in a desiccator under reduced pressure overnight at 4'C. The sections were then treated with 10 mM sodium phosphate buffer, pH 7.4, containing 150 mM NaCl, 5 mM Na2EDTA, 0.1076 NaN3, and 0.2% bovine serum al bumin (buffer A) for 15 min at room temperature. The treated sections were then incubated in a fresh volume of buffer A containing 0. Effect of HR720 on Ang II-induced contraction in iso lated human gastroepiploic artery and rabbit aorta The gastroepiploic artery specimens were isolated from omenta which were attached to the resected stomachs from 16 patients, aged 39 79 years, during surgery for the treatment of gastric cancer in our hospital. Descend ing thoracic aortae were removed from male Japanese White rabbits (1.7-2.8 kg, Japan SLC) under sodium pentobarbital anesthesia (60 mg/kg). Human gastro epiploic arteries and rabbit aortae were cut into helical strips 2 to 2.5-mm-wide and 20-mm-long and 3.0-mm wide and 20-mm-long, respectively. These strips were mounted in a 5-ml tissue bath containing Tyrode's solu tion composed of 137 mM NaCl, 2.7 mM KC1, 1.8 mM CaC12, 1.1 MM MgC12, 0.42 mM NaH2PO4, 12 mM NaHCO3 and 5.7 mM glucose. The Tyrode's solution was kept at 37C and gassed continuously with 5076 C02 in oxygen. The initial resting tension was set at 1.5 g for human arterial strips and 2.O g for rabbit aortic strips. Isometric tension signals were detected with a force-dis placement transducer (Nihon Kohden, Tokyo), amplified and displayed on a chart recorder (Pantos, Kyoto). To avoid possible interference with responses to Angs that affect biosynthesis and release endogenous prostanoids (19), 1 pM indomethacin was added to the medium throughout the experiments.
After an equilibration period of 90 120 min, the strips were stimulated by add ing 30 mM KC1, and the response of each strip served as the reference for the agonist-induced contraction of the corresponding strip. The control cumulative concen tration-response curve for Ang II (1 x 10-10-3 x 10 ' M) was first obtained. As previously reported (20) , responses to Ang II were stabilized with sufficient reproducibility after the second or third doses; therefore, the response after the third or fourth dose was regarded as the control response for the respective strips. After the maximum contractile response was reached, the strips were rinsed four times over a 1-hr period and were allowed to relax to the baseline tension. Then the prepared strips were incu bated with various concentrations of antagonists for 30 min prior to the addition of agonists. To evaluate the potency of the antagonists, the pD'2 or pA2 values were determined according to the methods described by Van Rossum (21) and Arunlakshana and Schild (22) .
Verification of the specificity of HR720
To test the specificity of HR720, contractile responses to KCI (10-60 mM), norepinephrine (1 x 10-'-3 x 10 6 M) and serotonin (1 x 10 -8-3 x 10 5 M) were examined in rabbit arteries before and after a 30-min incubation with 1 x 10 5 M HR720.
Reversibility of the inhibitory effects of HR720
After the equilibration period, the control contractile response to 3 x 10 8 M Ang II was obtained in isolated rabbit aortas. After the incubation with 1 x 10 -9 M HR720 for 30 min, the strips were stimulated with Ang II (3 x 10-8 M) in the presence of 1 x 10 9 M HR720. Then the strips were washed and restimulated with the same concentration of Ang II at 60 min and 120 min later.
Interaction between HR720 and losartan
To study the interaction between HR720 and losartan, the strips were first incubated with 1 x 10-9 M HR720 or its vehicle for 30 min. Losartan at a concentration of 1 x 10 I to 10 5 M or its vehicle was then applied to the strips for an additional 20-min incubation. The cumulative concentration-response curve for Ang II was then ob tained.
Inhibitory effects on Ang II-induced pressor response in normotensive hamsters
Six-week-old male Syrian hamsters weighing 90-110 g were supplied by Japan SLC and were anesthetized with sodium pentobarbital (50 mg/kg, i.p.). The left carotid artery and femoral vein were cannulated with a catheter (PE-10; Clay Adams, Parsippany, NJ, USA) filled with heparinized saline. The arterial catheter was connected to a pressure transducer (TP-200T, Nihon Kohden), and mean arterial pressure (MAP) was continuously recorded on a pen-writing recorder (RJG-4028, Nihon Kohden). After MAP was stabilized, 100 ng/kg Ang II was ad ministered via the venous catheter. The intravenous ad ministration of Ang II was repeated until constant pres sor responses were obtained, and then 0.3 or 1 mg/kg HR720 or CV-11974 was administered via the venous catheter. The control animals received the same volume of saline.
Drugs
HR720 was synthesized at Nippon Roussel (Tokyo). CV-11974 and losartan were a gift from Nippon Roussel. Ang II was purchased from Peptide Institute, Inc.
(Osaka).
Statistical analyses
All numerical data were expressed as the mean±S.E.M.
Differences were considered significant when the P values were less than 0.05 with Student's t-test or Dunnett's test.
RESULTS

Interaction of HR 720 and CV-11974 with Ang II recep tors evaluated by in vitro autoradiography
Because nonspecific binding determined in the presence of 0.5 aM unlabeled [Sar',Ile8]Ang II was very weak and no visible image was observed on the X-ray films, the data presented indicate the specific binding (Fig. 2) . As shown in Fig. 2A , dense radioligand binding was observed both in the zona glomerulose of the adrenal cortex and in the medulla. In the rat adrenal cortex, AT, receptors are known to be predominant, whereas in the rat adrenal medulla, AT2 receptors are known to be predominant (6) . The inhibitory effect of HR720 on the 1251-[Sar',Ile8]Ang II binding was very similar to that of CV-11974 (Fig. 2: B and C). HR720 potently inhibited the radioligand binding to the adrenal cortex, but it only very weakly inhibited binding to the adrenal medulla (Fig. 2C) . Quantitation of the autoradiograms revealed that the IC50 value for HR720 in the adrenal cortex was 1.5 x 10 8 M, which was similar to that for CV-11974 (3.2 x 10 8 M) (Fig . 3A) . The IC50 of HR720 for the adrenal medulla was 1.4 x 10.6 M, approximately 100 times less potent for AT2 than AT,-receptor sites (Fig. 3B ). These data indicate that HR720 inhibited AT, receptors selectively, but still ex hibited affinity for AT2 receptors. The IC50 value for CV 11974 in the rat adrenal medulla was higher than 1 x 10 5 M (Fig. 2B and Fig. 3B ). Scatchard plots obtained were best fitted to a single site model with a Kd value of 2.0--1-0.61 nM (n=3) for the adrenal cortex and 2.5--L0.04 nM (n = 3) for the adrenal medulla (Fig. 3 ).
Antagonism to A ng II-induced contractile responses
In the rabbit aorta, HR720 shifted the concentration contractile response curve for Ang II to the right and downward and reduced the maximal response to Ang II by 83.3±4.3%, 55.7±6.6% and 25.1±3.5%%o at 1 x 10 10, 3 x 10 -10 and 1 x 10 9 M, respectively (Fig. 4A) . The calculated pD'2 of HR720 was 9 .40+0.07 (n=6). CV-11974 also shifted the concentration-contractile response curve for Ang II to the right and downward; it reduced the maximal response to Ang II by 96.4± 1.910, 69.8±3.3076, 24.0±2.3°70 and 7.8± 1.7% at 3 x 10 11, 1 x 10--'0, 3 x 10-10 and 1 x 10-9 M, respectively (Fig. 4B) . The pD'2 value of CV-11974 was 9.84±0.07 (n=6). As shown in Fig. 4C , losartan at 3 x 10-9, 1 x 10-8 and 3 x 10 8 M produced a parallel rightward shift of the con centration-contractile response curve for Ang II with a pA2 value of 8.40±0.05 (slope: 0.97±0.08, n=6) without affecting the maximal contractile response. In the human gastroepiploic artery, both HR720 and CV-11974 inhibited the contractile responses to Ang II in a similar manner to the rabbit aorta (Fig 5: A and B) . A pD'2 value of 9.61±0.14 (n=8) for HR720 and 10.00±0.19 (n=8) for CV-11974 were obtained. contraction in isolated vessels.
Specificity of the antagonism HR720 (1 x 10-5 M) did not affect the concentration response curves of KCl (10-60 mM), norepinephrine (1 x 10-9-3 x 10-6 M) and serotonin (1 x 10-8-3 x 10-5 M) in the rabbit aortae (Fig. 6 ). In the absence of Ang II, HR720 did not affect the basal resting tension of rabbit aortae at 1 x 10-5 M. 
Reversible inhibitory effect of HR720
As shown in Fig. 7 , the inhibition of the Ang II (3 x 108 M)-induced contraction by the pretreatment with 
HR720
(1 x 10-9 M) for 30 min (75.407o inhibition, n=4) recovered 2 hr after washing (3010 inhibition, n=4).
Effects of losartan on insurmountable antagonism of HR 720
As shown in Fig. 8, HR720 shifted the concentration contractile response curve for Ang II to right and down ward with a depressed maximal response to Ang II, but losartan at 1 x 10 5 M shifted the concentration-contrac tile response curve for Ang II to the right in a parallel fashion without altering the maximal response. As the concentrations of losartan were raised in the incubation solution to 1 x 10', 10-6 and 10 5 M, the reduced maxi mal responses to Ang II induced by HR720 were restored depending on the increasing concentration of losartan, to 57.2010, 78.6010 and 90.2% of the control, respectively.
Inhibitory effects on the Ang II-induced pressor response in normotensive hamsters HR720 administered intravenously did not affect the baseline blood pressure. Compared to the vehicle-treated hamsters, bolus intravenous injection of HR720 (0.3 and 1 mg/kg) inhibited the pressor response to Ang II (100 ng/kg, i.v.) dose-dependently (Fig. 9 ). The inhibitory effect was evident immediately after the injection, and continued for the following 4 hr. The inhibitory effects of HR720 were similar to those of CV-11974 in this system.
DISCUSSION
Losartan is the prototypic non-peptide AT,-receptor antagonist and the first of a new class of pharmaco logical and therapeutic agents, and CV-11974, active metabolite of TCV-116, is known to be one of the most potent non-peptide AT,-receptor antagonist (6) . These two agents have been widely used to study the physio logical and path ophysiological roles of AT, receptors (6, 7) . In this study, the specificity and potency of HR720 were evaluated in comparision with those of losartan and CV-11974.
The present study demonstrated that HR720 is a potent, highly specific non-peptide receptor antagonist of the AT,-receptor subtype without agonistic activity. HR720, like CV-11974, inhibited 125I-[Sar1,I1e8]Ang II binding to the rat adrenal cortex where AT, receptors predominate; its IC50 value (1.5 x 10-8 M) was similar to that of CV-1 1974 (3.2 x 10 -8 M). In the adrenal medulla where AT2-receptors are predominant, HR720 was 100 times less potent than in the cortex. In isolated rabbit aorta and human gastroepiploic arter ies, HR720 and CV-11974 reduced the maximal response to Ang II and caused a non-parallel shift of the con centration-response curves to the right, suggesting non competitive antagonism. In contrast, losartan caused a parallel rightward shift of the dose-response curve for Ang 11 without affecting the maximal response. The inhibitory effect of HR720 on the response to Ang II stems from the antagonism specific to AT, receptors, not from a non-specific vasodilating effect, because in the ab sence of Ang II, HR720 neither affected the basal resting tension of both rabbit aorta and human gastroepiploic artery nor altered the contractile responses to KCI, norepinephrine and serotonin. In the present study, HR720 was shown to be an insur mountable antagonist of the Ang 11-induced contraction. Several possible mechanisms (23) (24) (25) may be involved in the insurmountable antagonism by HR720. Since HR720 did not affect the reponse to agents other than Ang II, it is unlikely that HR720 displayed insurmountable Ang 11 antagonism due to binding to the sites other than AT, receptors. The second, insurmountable antagonism may not be attributable to irreversible antagonism, such as covalent bond formation with the receptor, because in creasing doses of losartan reversed its reduced maximal response to Ang II at 10-' M and completely reversed it at 10-5 M. Another mechanism to be considered is pseudo-irreversible antagonism like very slow dissociation from the receptor. In rabbit aorta pretreated with HR720 at 10-9 M, it took at least 2 hr to restore completely the sensitivity to Ang II. However, losartan, a surmountable antagonist for AT, receptor, was also resistant to repeat ed washing and it took more than 1 hr to dissociate com pletely from the receptor sites (data not shown). There fore, pseudoirreversible antagonism does not seem to explain the different mode of antagonism between HR720 and losartan. The exact mechanism still needs to be clarified.
HR720 caused the maximal inhibition of the Ang II induced response immediately after the intravenous ad ministration to hamsters, and so did CV-11974, the active form of TCV-116 (26) . The inhibitory effect of intra venously administered HR720 on the pressor response to Ang II lasted for at least 8 hr. The ptoency of HR720 was similar to that of CV-11974. Dose-dependent inhibition of the Ang II-induced pressor response was also ob served, as reported previously (27) .
In conclusion, HR720 is an AT,-receptor-specific and long-lasting antagonist without agonistic activity. In vivo and in vitro potencies of HR720 are comparable to those of CV-11974, a potent non-peptide AT,-receptor antago nist (26) . These pharmacological properties suggest that HR720 should be a useful pharmacological compound for treating cardiovascular disease in which Ang II is pathogenically involved.
